XenoPort

XenoPort, Glaxo Migrane Drug Fails To Outperform Placebo
WSJ Online
Wed, 07/7/10 - 09:27 am
XenoPort
GSK
migraines
clinical trials
What ASCO Can Tell You About Biotechs
Investopedia
Sat, 05/29/10 - 09:24 am
biotech
Celgene
Delcath
Roche
Ziopharm
ZymoGenetics
XenoPort
Update on Xenoport's Horizant
Yahoo/Zacks.com
Thu, 05/27/10 - 06:24 pm
Horizant
XenoPort
What Investors Think About XenoPort
Motley Fool
Thu, 05/20/10 - 06:38 pm
XenoPort
What Investors Think About XenoPort
Motley Fool
Thu, 05/20/10 - 11:13 am
XenoPort
Seven Biotech Drugs to Watch in the Second Quarter
BNET Pharma
Tue, 04/13/10 - 10:35 am
Acorda Therapeutics
AMPYRA
Cell Therapeutics
pixantrone
Pixuvri
Dendreon
Provenge
InterMune
Esbriet
Pozen
Vimovo
XenoPort
Horizant
Astellas
OSI Pharmaceuticals
Ironwood
XenoPort Narrows Focus, Cuts Jobs
Forbes
Mon, 03/8/10 - 04:25 pm
XenoPort
layoffs
restructuring
Horizant
For Biotech in 2010, It's Déjà Vu All Over Again
Seeking Alpha
Mon, 03/8/10 - 10:23 am
Alkermes
Amylin
MannKind
Cell Therapeutics
Dendreon
Isis Pharmaceuticals
Amag Pharmaceuticals
XenoPort
Novelos Therapeutics
Adventrx
Delcath
The FDA Fires a Warning Shot at Disease-Mongering Drug Companies -- Maybe
BNET Pharma
Wed, 02/24/10 - 05:26 pm
FDA
XenoPort
restless legs syndrome
Horizant
The Year For Biotechs
Investopedia
Tue, 02/23/10 - 11:25 am
Amgen
Dendreon
XenoPort
Drug stocks turn higher; Shire, XenoPort gain
MarketWatch
Sat, 02/20/10 - 10:59 am
Shire
XenoPort
Even Me-Too Drugs Get The Blues
Forbes
Thu, 02/18/10 - 11:03 am
me-too drugs
GSK
XenoPort
Glaxo, XenoPort face additional FDA questions
Yahoo/AP
Thu, 02/18/10 - 09:26 am
FDA
GSK
XenoPort
Horizant
restless legs syndrome
Glaxo savings plan may hit XenoPort partnership
Yahoo/AP
Thu, 02/4/10 - 03:28 pm
GSK
XenoPort
partnerships
Xenoport Says U.S. FDA Won’t Require Advisory Panel
Bloomberg
Fri, 01/15/10 - 08:55 am
FDA
restless legs syndrome
XenoPort
GSK
Astellas
XenoPort and Glaxo says FDA review of neuropathic pain drug extended 3 months, to Feb. 2010
Yahoo/AP
Mon, 11/9/09 - 10:10 am
XenoPort
FDA
GSK
neuropathic pain
Biotech Calendar: Key Dates for November
TheStreet.com
Mon, 11/2/09 - 08:52 am
XenoPort
Vertex Pharmaceuticals
Schering Plough
Pharmasset
Merck
InterMune
Cephalon
Cadence Pharmaceuticals
biotech
GlaxoSmithKline, Xenoport report positive midstage study results from potential pain drug
Yahoo/AP
Thu, 09/17/09 - 11:16 am
GSK
XenoPort
neuropathic pain
XenoPort ends study of back spasm drug candidate
Yahoo/AP
Tue, 09/8/09 - 07:14 am
XenoPort
drug trials
XenoPort says positive trial of spinal cord drug
Marketwatch
Tue, 06/30/09 - 08:22 am
XenoPort
drug trials

Pages